OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
15
Results
Show all
Save search
Copy query
Show results for
Unknown
(15)
Publication Date
Release Date
2023
(3)
2024
(2)
2022
(2)
2014
(2)
2026
(1)
2025
(1)
2019
(1)
2013
(1)
2009
(1)
2006
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Ecosystem service flows from a migratory species: Spatial subsidies of the northern pintail.
Not available
S-EPMC6297107
|
biostudies-literature
Cite
Bruton's tyrosine kinase (BTK) function is important to the development and expansion of chronic lymphocytic leukemia (CLL).
Not available
S-EPMC3931190
|
biostudies-literature
Cite
Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes.
Not available
S-EPMC3795457
|
biostudies-literature
Cite
Safety and reactogenicity of an MSP-1 malaria vaccine candidate: a randomized phase Ib dose-escalation trial in Kenyan children.
Not available
S-EPMC1851726
|
biostudies-literature
Cite
Second generation CD2-targeting LFA-3 fusion protein SBT115301 to restore immune homeostasis in autoimmune disease.
Not available
S-EPMC12146614
|
biostudies-literature
Cite
Ibrutinib treatment ameliorates murine chronic graft-versus-host disease.
Not available
S-EPMC4347242
|
biostudies-literature
Cite
Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya.
Not available
S-EPMC2650803
|
biostudies-literature
Cite
Safety, Immunogenicity, and Efficacy of the NVX-CoV2373 COVID-19 Vaccine in Adolescents: A Randomized Clinical Trial.
Not available
S-EPMC10536880
|
biostudies-literature
Cite
SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals: A Secondary Cross-Protocol Analysis of 4 Randomized Trials.
Not available
S-EPMC11117088
|
biostudies-literature
Cite
Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials.
Not available
S-EPMC10346130
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets